Nuevas investigaciones para mejorar la salud global | 17 MAR 14

Biología y medicina del ejercicio

Los mecanismos íntimos mediante los cuales el ejercicio influye en la salud y sus aplicaciones clínicas.
Autor/a: Dres. Bamman MM, Cooper DM Mayo Clin Proc. 2014;89:148-153
INDICE:  1.  | 2. Referencias
Referencias

1. Wei M, Kampert JB, Barlow CE, et al. Relationship between low cardiorespiratory fitness and mortality in normal-weight, overweight, and obese men. JAMA. 1999; 282(16):1547-1553.
2. Kodama S, Saito K, Tanaka S, et al. Cardiorespiratory fitness as a quantitative predictor of all-cause mortality and cardiovascular events in healthy men and women: a meta-analysis. JAMA. 2009; 301(19):2024-2035.
3. Kaminsky LA, Arena R, Beckie TM, et al; American Heart Association Advocacy Coordinating Committee, Council on Clinical Cardiology, and Council on Nutrition, Physical Activity and Metabolism. The importance of cardiorespiratory fitness in the United States: the need for a national registry; a policy statement from the American Heart Association. Circulation. 2013; 127(5):652-662.
4. Garber CE, Blissmer B, Deschenes MR, et al; American College of Sports Medicine. American College of Sports Medicine position stand: quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults; guidance for prescribing exercise. Med Sci Sports Exerc. 2011; 43(7):1334-1359.
5. Bateman LA, Slentz CA, Willis LH, et al. Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol. 2011; 108(6):838-844.
6. Daar AS, Singer PA, Persad DL, et al. Grand challenges in chronic non-communicable diseases. Nature. 2007; 450(7169):494-496.
7. US Department of Health and Human Services. Physical Activity Guidelines Advisory Committee Report, 2008. Washington, DC: US Dept of Health and Human Services; 2008. http://www.health gov/paguidelines/Report/pdf/CommitteeReport.pdf.
Accessed July 21, 2011.
8. Mokdad AH, Marks JS, Stroup DF, Gerberding JL. Actual causes of death in the United States, 2000 [published correction appears in JAMA. 2005; 293(3):293-294, 298]. JAMA. 2004; 291(10):1238-1245.
9. Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012; 2(2):1143-1211.
10. American College of Sports Medicine and American Medical Association. Exercise is Medicine website. http://www.exerciseismedicine.org/index2.htm. Published 2008. Acccessed September 10, 2011.
11. National Institutes of Health. Restructuring the National Institutes of Health to advance translational science. National Institutes of Health website. http://www.nih.gov/about/director/ncats/NCATSbudget.pdf. Published 2011. Accessed November 30, 2011.
12. Booth FW, Shanely RA. The biochemical basis of the health effects of exercise: an integrative view. Proc Nutr Soc. 2004; 63(2):199-203.
13. He C, Bassik MC, Moresi V, et al. Exercise-induced BCL2-regulated autophagy is required for muscle glucose homeostasis [published correction appears in Nature. 2013; 503(7474):146]. Nature. 2012; 481(7382):511-515.
14. Boström P, Wu J, Jedrychowski MP, et al. A PGC1-a-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012; 481(7382):463-468.
15. SeldinMM, Peterson JM, Byerly MS,Wei Z,WongGW. Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem. 2012; 287(15):11968-11980.
16. Pedersen BK, Febbraio MA. Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol. 2012; 8(8):457-465.
17. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403.
18. US Food and Drug Administration. Guidance for Industry: Developing Products for Weight Management. 2007 draft. US Food and Drug Administration website. www.fda.gov/downloads/Drugs/.../Guidances/ucm071612.pdf. Accessed February 16, 2012.
19. Martin B, Ji S, Maudsley S, Mattson MP. “Control” laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A. 2010; 107(14):6127-6133.
20. Lenz TL. The effects of high physical activity on pharmacokinetic drug interactions. Expert Opin Drug Metab Toxicol. 2011; 7(3):257-266.
21. Yarasheski KE, Cade WT, Overton ET, et al. Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. Am J Physiol Endocrinol Metab. 2011; 300(1):E243-E251.
22. Mikus CR, Boyle LJ, Borengasser SJ, et al. Simvastatin impairs exercise training adaptations. J Am Coll Cardiol. 2013; 62(8):709-714.
23. Maass AH, Buck S, Nieuwland W, Brügemann J, van Veldhuisen DJ, Van Gelder IC. Importance of heart rate during exercise for response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009; 20(7):773-780.
24. Narkar VA, Downes M, Yu RT, et al. AMPK and PPARdelta agonists are exercise mimetics. Cell. 2008; 134(3):405-415.
25. Lamb SE, Guralnik JM, Buchner DM, et al. Factors that modify the association between knee pain and mobility limitation in older women: the Women’s Health and Aging Study. Ann Rheum Dis. 2000; 59(5):331-337.
26. Singh JA, Lewallen DG. Predictors of activity limitation and dependence on walking aids after primary total hip arthroplasty. J Am Geriatr Soc. 2010; 58(12):2387-2393.
27. Miyai N, Arita M, Miyashita K, Morioka I, Shiraishi T, Nishio I. Blood pressure response to heart rate during exercise test and risk of future hypertension. Hypertension. 2002; 39(3):761-766.
28. Ziegler MG, Ruiz-Ramon P, Shapiro MH. Abnormal stress responses in patients with diseases affecting the sympathetic nervous system. Psychosom Med. 1993; 55(4):339-346.
29. Srinivasan S, Ausk BJ, Prasad J, et al. Rescuing loading induced bone formation at senescence. PLoS Comput Biol. 2010; 6(9):pii. e1000924.
30. Timmons JA, Knudsen S, Rankinen T, et al. Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. J Appl Physiol (1985). 2010; 108(6):1487-1496.
31. Bouchard C. Overcoming barriers to progress in exercise genomics. Exerc Sport Sci Rev. 2011; 39(4):212-217.
32. Slentz CA, Bateman LA, Willis LH, et al. Effects of aerobic vs.resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT/RT. Am J Physiol Endocrinol Metab. 2011; 301(5): E1033-E1039.
33. Herring MP, Sailors MH, Bray MS. Genetic factors in exercise adoption, adherence and obesity [published online ahead of print September 15, 2013]. Obes Rev. http://dx.doi.org/10.1111/obr.12089.
34. Unick JL, Beavers D, Jakicic JM, et al; Look AHEAD Research Group. Effectiveness of lifestyle interventions for individuals with severe obesity and type 2 diabetes: results from the Look AHEAD trial. Diabetes Care. 2011; 34(10):2152-2157.
35. Look AHEAD Research Group; Wing RR, Bolin P, Brancati FL, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013; 369(2):145-154.
36. Joyner MJ, Green DJ. Exercise protects the cardiovascular system: effects beyond traditional risk factors. J Physiol. 2009; 587(pt 23):5551-5558.
37. Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low-density lipoprotein independent of body fat phenotypes in older men and women. Metabolism. 2007; 56(4): 444-450.
38. Green DJ, O’Driscoll G, Joyner MJ, Cable NT. Exercise and cardiovascular risk reduction: time to update the rationale for exercise? J Appl Physiol (1985). 2008; 105(2):766-768.
39. Ridker PM, Danielson E, Fonseca FA, et al; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359(21):2195-2207.
40. Kwan G, Balady GJ. Cardiac rehabilitation 2012: advancing the field through emerging science. Circulation. 2012; 125(7):e369-e373.
41. Sveen ML, Jeppesen TD, Hauerslev S, Krag TO, Vissing J. Endurance training: an effective and safe treatment for patients with LGMD2I. Neurology. 2007; 68(1):59-61.
42. Goodwin VA, Richards SH, Taylor RS, Taylor AH, Campbell JL. The effectiveness of exercise interventions for people with Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2008; 23(5):631-640.
 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024